|
Source
|
Web search www.sciencedaily.com/releases/2020/10/201013105750.… |
|
Organization
|
Ohio State University |
|
Website URL
|
news.osu.edu/stopping-lethal-lung-damage-fr… |
|
Market status
|
Early Stage Concept |
|
Industry
|
Medical |
|
Business models
|
B2C |
|
Product categories
|
Medicine + Medical Treatment |
|
Biotech components
|
Molecule |
|
Organization type(s)
|
University |
|
Funding types
|
University |
|
Notes
|
“The raging lung inflammation that can contribute to death from the flu can be stopped in its tracks by a drug derived from a naturally occurring human protein, a new animal study suggests...In mouse studies, all untreated animals given a lethal dose of influenza died within days. All but one of the infected mice treated with the experimental therapy not only survived, but remained energetic and kept weight on -- despite having high levels of the flu virus in their lungs...The experimental treatment is a heavy dose of MG53, part of a family of proteins that plays an essential role in cell membrane repair. Already identified as a potential therapy for conditions ranging from Alzheimer's disease to persistent skin wounds, MG53 was found in this study to prevent death from a lethal flu infection by blocking excessive inflammation -- without having any effect on the virus itself." |
Added 4 years ago
Last modified 4 years ago
